TP53 and non-small cell lung carcinoma: The mutational landscape of 31 bone oligometastatic NSCLC generated from targeted sequencing data is shown in Fig. 1A. The most frequently mutated genes in bone oligometastasis were EGFR (58%) and TP53 (55%).